Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
M01 Tool: An Automated, Comprehensive Computational Tool for Generating Small Molecule-Peptide Hybrids and Docking Them Into Curated Protein Structures Publisher Pubmed



M Sheikholeslami MAHSA ; Mh Nazari Mohammad HASAN ; A Fassihi AFSHIN
Authors

Source: BMC Bioinformatics Published:2025


Abstract

Background: The field of computational drug design is undergoing rapid advancements, highlighting the need for innovative methods to enhance the efficiency and accuracy of calculating ligand-receptor interactions. In this context, we introduce the M01 tool, a comprehensive computational package designed to facilitate the generation and docking of small molecule-peptide hybrids. M01 integrates several established tools, such as RDKit and EasyDock, into a user-friendly platform that automates the workflow from hybrid generation to docking simulations. This tool is particularly beneficial for researchers with limited chemistry expertise, helping them leverage advanced computational techniques. Results: The M01 tool features an intuitive interface for visualizing molecules and selecting connection points in generating new ligands. It also offers automated receptor preparation using UniProt or PDB IDs and generates default docking configuration files. Furthermore, it includes ligand preparation and docking capabilities through EasyDock and calculates molecular descriptors relevant to drug-likeness properties. Validation studies with peptide-alkoxyamine hybrids demonstrated the tool’s effectiveness, generating over 14,000 unique hybrid molecules and showcasing its versatility in drug design applications. Conclusions: The M01 tool represents a significant advancement in computational drug design, streamlining the process of creating hybrid molecules and conducting docking studies. Its ability to automate complex workflows and provide essential molecular insights can empower researchers and enhance the development of novel therapeutics, ultimately contributing to more efficient drug discovery efforts. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Identification of Novel 3-Hydroxy-Pyran-4-One Derivatives As Potent Hiv-1 Integrase Inhibitors Using in Silico Structure-Based Combinatorial Library Design Approach, Frontiers in Chemistry (2019)
2. Targeting and Ultrabroad Insight Into Molecular Basis of Resistance-Nodulation-Cell Division Efflux Pumps, Scientific Reports (2022)
3. Structural Analysis of Some Pyrrolopyrimidine Derivatives and Examining Their Binding Affinity Against the Cyclooxygenase-2 Enzyme, Turkish Computational and Theoretical Chemistry (2021)
Experts (# of related papers)
View all Related Experts
Afshin Fassihi (6)
Lotfollah Saghaie Dehkordi (4)
Other Related Docs
4. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-Trimethoxyphenyl)Methyl]-1,2,4-Triazole-3-Thione/Thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity, Archiv der Pharmazie (2016)
5. Computational Evaluation of Some Indenopyrazole Derivatives As Anticancer Compounds; Application of Qsar and Docking Methodologies, Journal of Enzyme Inhibition and Medicinal Chemistry (2013)
6. Effect of Biomolecular Conformation on Docking Simulation: A Case Study on a Potent Hiv-1 Protease Inhibitor, Iranian Journal of Pharmaceutical Research (2015)
7. Drug Repurposing Against Angiotensin-Converting Enzyme-Related Carboxypeptidase (Ace2) Through Computational Approach, Journal of Medical Signals and Sensors (2022)
8. Characterization of Adenosine Receptor in Its Native Environment: Insights From Molecular Dynamics Simulations of Palmitoylated/Glycosylated, Membrane-Integrated Human A2b Adenosine Receptor, Journal of Molecular Modeling (2012)
9. Pyprotmodel: An Easy to Use Gui for Comparative Protein Modeling, Journal of Molecular Graphics and Modelling (2022)
10. In Silico Effects of Steviol on Depression, Inflammation and Cancer Biomarkers, Biointerface Research in Applied Chemistry (2022)
11. In Silico Designing Breast Cancer Peptide Vaccine for Binding to Mhc Class I and Ii: A Molecular Docking Study, Computational Biology and Chemistry (2016)
12. Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel Sars-Cov-2 Nsp3 Mac1 Domain Inhibitors, Viruses (2023)
13. Molecular Modeling, Structure Activity Relationship and Immunomodulatory Properties of Some Lupeol Derivatives, Medicinal Chemistry Research (2013)
14. In Silico Design of Novel Fak Inhibitors Using Integrated Molecular Docking, 3D-Qsar and Molecular Dynamics Simulation Studies, Journal of Biomolecular Structure and Dynamics (2022)
15. Virtual Screening for the Identification of Potential Candidate Molecules Against Envelope (E) and Membrane (M) Proteins of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
16. In Silico Activity of As1411 Aptamer Against Nucleolin of Cancer Cells, Iranian Journal of Blood and Cancer (2020)
17. Molecular Modelling Study on Pyrrolo[2,3-B]Pyridine Derivatives As C-Met Kinase Inhibitors: A Combined Approach Using Molecular Docking, 3D-Qsar Modelling and Molecular Dynamics Simulation, Molecular Simulation (2020)
18. Gp41 Inhibitory Activity Prediction of Theaflavin Derivatives Using Ligand/Structure-Based Virtual Screening Approaches, Computational Biology and Chemistry (2019)
19. Prediction of Aptamer Affinity Using an Artificial Intelligence Approach, Journal of Materials Chemistry B (2024)
20. Virtual Screening of M3 Protein Antagonists for Finding a Model to Study the Gammaherpesvirus Damaged Immune System and Chemokine Related Diseases, BioImpacts (2013)